BAX and B-cell chronic lymphocytic leukemia: Fludarabine, a chemotherapeutic drug used in the treatment of a small subset of CLL patients alone or in combination with other chemotherapeutic or immunomodulatory drugs, enhances Bax activation and expression and promotes apoptosis of CLL cells (9, 10).